From Financial Modeling Prep: 2025-05-22 15:07:00

CEL-SCI Corporation, trading on the AMEX under the symbol CVM, executed a reverse stock split at a ratio of 30 for 1 on May 20, 2025, aiming to optimize its capital structure. This move is part of the biotechnology company’s efforts to enhance shareholder value and improve market positioning.

The reverse stock split led to a significant price drop of approximately 45.02%, with CVM’s current price standing at approximately $2.48. This decline of $2.03 highlights the challenges CEL-SCI faces in stabilizing its stock price and attracting investors despite active trading interest.

Despite the price drop, CEL-SCI’s market capitalization remains at around $7.52 million. The trading volume of 1,266,437 shares indicates ongoing investor interest in the company, showcasing potential opportunities for growth and market expansion. The reverse stock split is a strategic move to consolidate shares and potentially enhance the stock’s market appeal.



Read more at Financial Modeling Prep:: CEL-SCI Corporation’s Strategic Reverse Stock Spli…